Haldol im deltoid

Commonly Observed Adverse Reactions for INVEGA SUSTENNA ® : The most common adverse reactions in clinical trials in patients with schizophrenia (≥5% and twice placebo) were injection site reactions, somnolence/sedation, dizziness, akathisia and extrapyramidal disorder. No adverse events occurred at a rate of ≥5% and twice placebo during the 15-month double-blind, placebo-controlled study in patients with schizoaffective disorder. The following adverse reactions occurred more frequently (a ≥2% difference vs. placebo) in the long-term study in patients with schizoaffective disorder: weight increased, nasopharyngitis, headache, hyperprolactinemia, and pyrexia.

Possible risk factors for leukopenia/neutropenia include pre-existing low white blood cell count (WBC)/absolute neutrophil count (ANC) and history of drug-induced leukopenia/neutropenia. In patients with a history of a clinically significant low WBC/ANC or a drug-induced leukopenia/neutropenia, perform a complete blood count (CBC) frequently during the first few months of therapy. In such patients, consider discontinuation of Invega Sustenna ® at the first sign of a clinically significant decline in WBC in the absence of other causative factors.

Haldol im deltoid

haldol im deltoid

Media:

haldol im deltoidhaldol im deltoidhaldol im deltoidhaldol im deltoidhaldol im deltoid

http://buy-steroids.org